NCT07843277

Brief Summary

The goal of this observational study is to evaluate the effectiveness of implementing Koran Sepsis, or sepsis chart, a paper-based order set designed to guide the implementation of the One-hour Sepsis Bundle, in improving adherence to early sepsis management and reducing 7-day mortality among adult patients with sepsis presenting to the Emergency Department. The main questions it aims to answer are:

  • Receive standard clinical care for sepsis, with management documented during the first hour after sepsis is suspected or diagnosed.
  • Receive care guided by sepsis chart after its implementation at the participating hospital.
  • Have clinical data collected from their medical records, including adherence to the One-hour Sepsis Bundle and time to administration of broad-spectrum antibiotics.
  • Be followed for seven days to determine their mortality outcome. The study will include adult patients aged ≥18 years diagnosed with sepsis according to the Sepsis-3 definition who present to the Emergency Department and are admitted to one of two participating hospitals: Cipto Mangunkusumo and Fatmawati General Hospital.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
304

participants targeted

Target at P75+ for all trials

Timeline
15mo left

Started Sep 2026

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Sep 2026Dec 2027

Study Start

First participant enrolled

September 1, 2026

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

September 20, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 28, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

September 28, 2026

Status Verified

September 1, 2026

Enrollment Period

1.1 years

First QC Date

September 20, 2026

Last Update Submit

September 20, 2026

Conditions

Keywords

sepsisone-hour sepsis bundle

Outcome Measures

Primary Outcomes (1)

  • All-cause mortality

    All death attributed to any reason during study follow-up

    7 days

Secondary Outcomes (5)

  • Time to serum lactate measurement

    Within 1 hour after sepsis diagnosis

  • Time to Administration of Broad-Spectrum Antibiotics

    Within 24 hours after study inclusion

  • Time to blood culture collection

    Within 1 hour after sepsis diagnosis

  • Time to administration of 30 mL/kg crystalloid fluid

    Within 1 hour after sepsis diagnosis

  • Vasopressor administration

    Within 24 hour after sepsis diagnosis

Study Arms (1)

Sepsis patients

All patients included in the study, diagnosed with sepsis according to the sepsis-3 criteria

Other: Sepsis chart (koran sepsis)Other: Usual care

Interventions

Implementation of the sepsis one-hour bundle using a paper-based chart containing instructions for the recommended bundle components.

Sepsis patients

Standard sepsis management according to existing hospital practice without implementation of the study-specific sepsis one-hour bundle order set.

Sepsis patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients above ≥18 years diagnosed with sepsis in the emergency department in Cipto Mangunkusumo and Fatmawati General Hospital.

You may qualify if:

  • Adult patients aged ≥18 years.
  • Patients diagnosed with sepsis according to the Sepsis-3 definition, using the lactate-modified qSOFA score as a reference.
  • Patients presenting to the Emergency Department.
  • Patients who are subsequently admitted to one of the participating hospitals: Cipto Mangunkusumo and Fatmawati General Hospital.

You may not qualify if:

  • Incomplete clinical or outcome data required for the study analysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dr Cipto Mangunkusumo General Hospital

Jakarta Pusat, DKI Jakarta, 10430, Indonesia

RECRUITING

Fatmawati General Hospital

Jakarta Pusat, DKI Jakarta, 10430, Indonesia

NOT YET RECRUITING

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Sharifah Shakinah, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 20, 2026

First Posted

September 28, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

September 28, 2026

Record last verified: 2026-09

Locations